BE856710A - 5-m-tolyoxy-uracile, agent anti-ulceres - Google Patents

5-m-tolyoxy-uracile, agent anti-ulceres

Info

Publication number
BE856710A
BE856710A BE1008274A BE1008274A BE856710A BE 856710 A BE856710 A BE 856710A BE 1008274 A BE1008274 A BE 1008274A BE 1008274 A BE1008274 A BE 1008274A BE 856710 A BE856710 A BE 856710A
Authority
BE
Belgium
Prior art keywords
ulceres
tolyoxy
uracil
agent
ulceres agent
Prior art date
Application number
BE1008274A
Other languages
English (en)
Inventor
Ch A Lipinski
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of BE856710A publication Critical patent/BE856710A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60—Three or more oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
BE1008274A 1976-07-16 1977-07-11 5-m-tolyoxy-uracile, agent anti-ulceres BE856710A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/706,123 US4080454A (en) 1976-07-16 1976-07-16 5-M-Tolyloxyuracil, anti-ulcer agent

Publications (1)

Publication Number Publication Date
BE856710A true BE856710A (fr) 1978-01-11

Family

ID=24836300

Family Applications (1)

Application Number Title Priority Date Filing Date
BE1008274A BE856710A (fr) 1976-07-16 1977-07-11 5-m-tolyoxy-uracile, agent anti-ulceres

Country Status (29)

Country Link
US (1) US4080454A (fr)
JP (1) JPS5337673A (fr)
AR (1) AR213652A1 (fr)
AT (1) AT351561B (fr)
BE (1) BE856710A (fr)
CA (1) CA1061788A (fr)
CH (1) CH622512A5 (fr)
CS (1) CS212264B2 (fr)
DD (1) DD131556A5 (fr)
DE (1) DE2731736A1 (fr)
DK (1) DK139029B (fr)
EG (1) EG12762A (fr)
ES (1) ES460686A1 (fr)
FI (1) FI772183A (fr)
FR (1) FR2358399A1 (fr)
GB (1) GB1542178A (fr)
GR (1) GR68686B (fr)
HU (1) HU177713B (fr)
IL (1) IL52409A (fr)
LU (1) LU77764A1 (fr)
NL (1) NL7707729A (fr)
NO (1) NO772489L (fr)
PH (1) PH13190A (fr)
PL (1) PL103783B1 (fr)
PT (1) PT66808B (fr)
SE (1) SE421125B (fr)
SU (1) SU673169A3 (fr)
YU (1) YU171677A (fr)
ZA (1) ZA773927B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55158095A (en) * 1979-05-25 1980-12-09 Zenkosha Tokei Kk Controller for washing machine
JPS5822406U (ja) * 1981-08-04 1983-02-12 トキコ株式会社 消音器
US7776870B2 (en) 2005-08-22 2010-08-17 Melior Pharmaceuticals I, Inc. Methods for modulating Lyn kinase activity and treating related disorders
CA2678813A1 (fr) * 2007-02-20 2008-08-28 Melior Pharmaceuticals I, Inc. Procedes d'identification d'activateurs de lyn kinase
CA2693809A1 (fr) * 2007-07-23 2009-01-29 Melior Discovery, Inc. Procedes d'activation de irs-1 et akt
US8552184B2 (en) * 2008-07-03 2013-10-08 Melior Pharmaceuticals I, Inc. Compounds and methods for treating disorders related to glucose metabolism
WO2011150300A1 (fr) * 2010-05-28 2011-12-01 Melior Pharmaceuticals I, Inc. Prévention de la dégénérescence des cellules pancréatiques bêta
BR112019021140A2 (pt) 2017-04-10 2020-05-19 Univ Louisiana State composição, método para reduzir os níveis de glicose no sangue, ganho de peso ou níveis de depósito de gordura, ou tratamento, método de indução do bege de adipócitos ou prevenção da degeneração das células beta do pâncreas, e, ativador de lyn cinase e agonista de trpm8 para uso na redução dos níveis de glicose no sangue, ganho de peso ou níveis de depósito de gordura, ou tratamento.
WO2019164799A1 (fr) 2018-02-21 2019-08-29 Melior Pharmaceuticals I, Inc. Traitement de maladies hépatiques

Also Published As

Publication number Publication date
HU177713B (en) 1981-12-28
PL103783B1 (pl) 1979-07-31
GR68686B (fr) 1982-02-01
ES460686A1 (es) 1978-12-01
FR2358399B1 (fr) 1980-10-17
DK139029C (fr) 1979-05-07
CS212264B2 (en) 1982-03-26
PH13190A (en) 1980-01-16
LU77764A1 (fr) 1978-02-02
FI772183A (fr) 1978-01-17
US4080454A (en) 1978-03-21
AR213652A1 (es) 1979-02-28
EG12762A (en) 1979-12-31
JPS5337673A (en) 1978-04-06
CH622512A5 (fr) 1981-04-15
SU673169A3 (ru) 1979-07-05
DK318177A (fr) 1978-01-17
SE421125B (sv) 1981-11-30
GB1542178A (en) 1979-03-14
JPS5512017B2 (fr) 1980-03-29
DE2731736A1 (de) 1978-01-26
CA1061788A (fr) 1979-09-04
ZA773927B (en) 1978-05-30
AU2663877A (en) 1978-05-18
NO772489L (no) 1978-01-17
PL199633A1 (pl) 1978-04-10
ATA509277A (de) 1979-01-15
IL52409A0 (en) 1977-08-31
PT66808A (en) 1977-08-01
AT351561B (de) 1979-08-10
YU171677A (en) 1982-06-30
DD131556A5 (de) 1978-07-05
PT66808B (en) 1978-12-21
DK139029B (da) 1978-12-04
IL52409A (en) 1979-11-30
NL7707729A (nl) 1978-01-18
SE7707471L (sv) 1978-01-17
FR2358399A1 (fr) 1978-02-10

Similar Documents

Publication Publication Date Title
DK65077A (da) 2-piperazinyl-6,7-dimethoxyquinazoliner
SE438258B (sv) Nonjoniskt schamponeringsmedel
NL173134C (nl) Sandwichtoaster.
NO144607C (no) Pulverformig bindemiddel.
SE415322B (sv) Endoprotes, serskilt hoftledprotes
IT7826226A0 (it) Casa-natante.
FI73545B (fi) Vaexelriktare.
IT1113573B (it) L,3-diidro-eteroarilspiro isobenzo-furani
BE856710A (fr) 5-m-tolyoxy-uracile, agent anti-ulceres
NL7708544A (nl) Polyquaternaire uitvlokkingsmiddelen.
NL162451C (nl) Closetsok.
NL174450C (nl) Kurketrekker.
ES230876Y (es) Esqui-bob.
IT1084204B (it) Dsviluppatrice.
ES222715Y (es) Zapato-patin.
ES223988Y (es) Porta-archivadores.
DK138827B (da) Narresut.
SE7601493L (sv) Cirkrlsagklinga, serskilt for rojningsendamal
PL190698A1 (pl) Srodek przeciw karaczanom
ES222986Y (es) Nueva pecera.
ES218416Y (es) Candado-precinto.
ES222581Y (es) Sillon-lavacabezas.
ES221073Y (es) Burlete.
ES220673Y (es) Llavero-monedero.
ES221420Y (es) Caja-expositor.